🔗 Share this article

An underground economy for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.

Investigational Drug Gaining Popularity Via Social Media

The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Viewers are urged to message these accounts directly for supplier links, while also obtaining promotional offers.

Active Trade on Messaging Platforms

Separately, a robust market exists on messaging services, where communities with thousands of participants share “before and after” photos, injection guides and claims of rapid British shipping. Sellers promote the drug there before directing customers to other platforms for transactions.

Learning About The Experimental Drug

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could assist individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, physicians and chemists have cautions that the sale of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in users injecting products of uncertain source.

Several experts said the demand for retatrutide could be linked to the rising cost of approved slimming products such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the British medical regulations.

Some content creators try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate pharmaceutical, advertising, and customer regulations, risking fines, legal action or imprisonment.

Service Response and Content Elimination

According to TikTok, the service has removed problematic material and banned associated keywords and search suggestions. The organization stated it was dedicated to keeping the platform secure and allocating resources in strengthening enforcement strategies.

Digital Trading Operations

Research also found groups with up to nine thousand participants selling the experimental drug using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly brings up groups with numerous of members, filled with images of slimming results, glowing reviews and detailed guides for preparing or administering at residence.

After minutes of entering one community, a vendor shared WhatsApp details, where most purchases take place. The vendor sent an instruction manual and guaranteed shipping within two days. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None asked about weight, medical conditions or past usage.

Item Details and Pricing

Within these groups, messages display dark colored packages with Royal Mail stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20mg. When asked how much time a injector should last, sellers give conflicting responses ranging from a several days to “depends on your body”.

Service Moderation and Safety Actions

A representative for Telegram said it actively moderated harmful material on its service including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering materials they can’t verify. Although the science behind this drug is sound, these digital versions may not contain what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit injections are extremely risky. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her team has previously encountered individuals injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but buying from messaging apps or communication platforms is taking chances with your well-being,” stated the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been evaluated or approved by any government authority globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company investigational product not yet authorized … may subject patients to possibly significant medical dangers”.